Sales increase 57.99% to Rs 27.87 crore
Sun Pharma Advanced Research Company net loss reported at Rs 55.14 crore in the quarter ended September 2021 compared to a net loss of Rs 83.49 crore in the previous quarter ended September 2020. Sales increased by 57.99% to reach Rs 27.87 crore in the quarter ended September 2021 as against Rs 17.64 crore in the previous quarter ended September 2020.
DetailsQuarter endedSep 2021Sep 2020% Var.Sales27.8717.64 58 % of OPM-197.95-466.95 –PBDT-52.60-80.71 35 PBT-55.14-83.49 34 NP-55.14-83.49 34
Powered by Capital Market – Live News
(This story was not edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived to provide up-to-date information and commentary on developments that matter to you and have broader political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these difficult times resulting from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative views and cutting-edge commentary on relevant current issues.
However, we have a demand.
As we fight the economic impact of the pandemic, we need your support even more so that we can continue to provide you with more quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscriptions to our online content can only help us achieve the goals of providing you with even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
First published: Tue 02 November 2021. 08:42 IST